{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:22:11Z","timestamp":1790256131113,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1124\/mol.112.084269","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T20:53:56Z","timestamp":1366145636000},"page":"62-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Nrf2 Activators Attenuate the Progression of Nonalcoholic Steatohepatitis\u2013Related Fibrosis in a Dietary Rat Model"],"prefix":"10.1016","volume":"84","author":[{"given":"Rieko","family":"Shimozono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiji","family":"Asaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masateru","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie","family":"Kaino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.112.084269_bib1","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J Virol"},{"key":"10.1124\/mol.112.084269_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pharmthera.2009.06.006","article-title":"Therapeutic potential of dithiolethiones for hepatic diseases","volume":"124","author":"Brooks","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.112.084269_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Nonalcoholic steatohepatitis: definition and pathology","volume":"21","author":"Brunt","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1124\/mol.112.084269_bib4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1124\/mol.112.084269_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2009.11.007","article-title":"Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis","volume":"48","author":"Chowdhry","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/mol.112.084269_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2036.2006.02751.x","article-title":"Review article: Drug therapy for non-alcoholic fatty liver disease","volume":"23","author":"Comar","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/mol.112.084269_bib7","doi-asserted-by":"crossref","first-page":"33881","DOI":"10.1074\/jbc.274.48.33881","article-title":"Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells","volume":"274","author":"De Bleser","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.084269_bib8","doi-asserted-by":"crossref","first-page":"783976","DOI":"10.1155\/2011\/783976","article-title":"Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation","volume":"2011","author":"Fon Tacer","year":"2011","journal-title":"J Lipids"},{"key":"10.1124\/mol.112.084269_bib9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/hep.510290346","article-title":"Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C\/EBPbeta-dependent mechanism in rat hepatic stellate cells","volume":"29","author":"Garc\u00eda-Trevijano","year":"1999","journal-title":"Hepatology"},{"key":"10.1124\/mol.112.084269_bib10","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.23941","article-title":"Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice","volume":"52","author":"Gupte","year":"2010","journal-title":"Hepatology"},{"key":"10.1124\/mol.112.084269_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.112.084269_bib12","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.freeradbiomed.2004.02.075","article-title":"Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles","volume":"36","author":"Itoh","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/mol.112.084269_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev"},{"key":"10.1124\/mol.112.084269_bib14","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1096\/fj.02-0406fje","article-title":"Oltipraz regenerates cirrhotic liver through CCAAT\/enhancer binding protein-mediated stellate cell inactivation","volume":"16","author":"Kang","year":"2002","journal-title":"FASEB J"},{"key":"10.1124\/mol.112.084269_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbrc.2004.01.038","article-title":"Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet","volume":"315","author":"Kawaguchi","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.112.084269_bib16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.2042-7158.2011.01259.x","article-title":"Oltipraz therapy in patients with liver fibrosis or cirrhosis: a randomized, double-blind, placebo-controlled phase II trial","volume":"63","author":"Kim","year":"2011","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/mol.112.084269_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/MCB.01080-08","article-title":"The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds","volume":"29","author":"Kobayashi","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.112.084269_bib18","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.cca.2011.04.013","article-title":"The role of oxidative stress in non-alcoholic steatohepatitis","volume":"412","author":"Koek","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1124\/mol.112.084269_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.toxlet.2004.06.006","article-title":"Oltipraz, 3H-1,2-dithiole-3-thione, and sulforaphane induce overlapping and protective antioxidant responses in murine microglial cells","volume":"153","author":"Konwinski","year":"2004","journal-title":"Toxicol Lett"},{"key":"10.1124\/mol.112.084269_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF03401947","article-title":"Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione","volume":"7","author":"Kwak","year":"2001","journal-title":"Mol Med"},{"key":"10.1124\/mol.112.084269_bib21","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1074\/jbc.M211898200","article-title":"Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival","volume":"278","author":"Kwak","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.084269_bib22","doi-asserted-by":"crossref","first-page":"11069","DOI":"10.1074\/jbc.M111490200","article-title":"Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis","volume":"277","author":"Murphy","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.084269_bib23","first-page":"5042","article-title":"High incidence of hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats","volume":"52","author":"Nakae","year":"1992","journal-title":"Cancer Res"},{"key":"10.1124\/mol.112.084269_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/bj20030754","article-title":"Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence","volume":"374","author":"Nioi","year":"2003","journal-title":"Biochem J"},{"key":"10.1124\/mol.112.084269_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.freeradbiomed.2011.11.012","article-title":"Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-\u03b2\/Smad signaling","volume":"52","author":"Oh","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/mol.112.084269_bib26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molcel.2006.01.013","article-title":"Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer","volume":"21","author":"Padmanabhan","year":"2006","journal-title":"Mol Cell"},{"key":"10.1124\/mol.112.084269_bib27","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bcp.2008.12.028","article-title":"Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes","volume":"77","author":"Reisman","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.112.084269_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.taap.2008.12.024","article-title":"CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes","volume":"236","author":"Reisman","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/mol.112.084269_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cytogfr.2005.09.008","article-title":"Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis","volume":"17","author":"Roberts","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1124\/mol.112.084269_bib30","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.112.084269_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2009.08.022","article-title":"Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide","volume":"620","author":"Shin","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.112.084269_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1113\/expphysiol.1997.sp004024","article-title":"Oxidative stress: oxidants and antioxidants","volume":"82","author":"Sies","year":"1997","journal-title":"Exp Physiol"},{"key":"10.1124\/mol.112.084269_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/jhep.2003.50290","article-title":"Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis","volume":"38","author":"Sreekumar","year":"2003","journal-title":"Hepatology"},{"key":"10.1124\/mol.112.084269_bib34","doi-asserted-by":"crossref","first-page":"G283","DOI":"10.1152\/ajpgi.00296.2009","article-title":"Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice","volume":"298","author":"Sugimoto","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/mol.112.084269_bib35","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.112.084269_bib36","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2337\/db07-0714","article-title":"Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis","volume":"57","author":"Valenti","year":"2008","journal-title":"Diabetes"},{"key":"10.1124\/mol.112.084269_bib37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/mol.112.084269_bib38","doi-asserted-by":"crossref","first-page":"17058","DOI":"10.1074\/jbc.M100754200","article-title":"Identification of novel TGF-beta \/Smad gene targets in dermal fibroblasts using a combined cDNA microarray\/promoter transactivation approach","volume":"276","author":"Verrecchia","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.112.084269_bib39","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s00125-010-2001-8","article-title":"Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL\/6J mice","volume":"54","author":"Yu","year":"2011","journal-title":"Diabetologia"},{"key":"10.1124\/mol.112.084269_bib40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.taap.2010.03.016","article-title":"Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet","volume":"245","author":"Zhang","year":"2010","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24037398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24037398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.112.084269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T06:14:42Z","timestamp":1739945682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24037398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0026895X24037398"],"URL":"https:\/\/doi.org\/10.1124\/mol.112.084269","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf2 Activators Attenuate the Progression of Nonalcoholic Steatohepatitis\u2013Related Fibrosis in a Dietary Rat Model","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.112.084269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}